Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal...
1 insider purchase on record · latest filing 2025-11-20.
Insiders have also filed 47 sale transactions at IVVD.